Sun.Nov 10, 2024

article thumbnail

Canada Reports First Human Case Of H5N1 Bird Flu

Forbes Healthcare

A teenager in British Columbia, Canada has been hospitalized with a presumed case of H5N1 bird flu, the first detected human case in the country in the current outbreak.

Hospital 143
article thumbnail

Dr. Vinay Prasad: “I Don’t Believe in Forgiveness Because in My Opinion These Pieces of S**t Are Still Lying.”

Science Based Medicine

Mass purges and prosecutions of scientists have happened before. We shouldn't pretend they can't happen here. The post Dr. Vinay Prasad: “I Don’t Believe in Forgiveness Because in My Opinion These Pieces of S**t Are Still Lying.” first appeared on Science-Based Medicine.

107
107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Less Than 1 In 5 Americans Who Are Eligible Are Getting Screen For Lung Cancer. Here’s Why

Forbes Healthcare

Less than 20% (19.6%) of Americans who are eligible to get screened for lung cancer are getting the test they need, according to research published in JAMA Network Open.

Tests 132
article thumbnail

How Montefiore is Training the Next Generation of Nurse Practitioners

Minority Nurse

Post-graduate training programs for newly practicing nurse practitioners are crucial because they allow new clinicians to feel supported and safe and truly excel in the field of primary care. In the long term, they have been shown to improve confidence, reduce burnout, and keep providers practicing. As Nurse Practitioners are increasingly entering primary care at higher rates than our physician colleagues, these training programs are crucial to increasing the primary care workforce.

article thumbnail

Many Bird Flu Infections Among Dairy Workers Go Undetected

Forbes Healthcare

The number of H5N1 bird flu cases in dairy cattle workers in the U.S. may be much higher than reported, indicates a new CDC study.

145
145
article thumbnail

Rebate Game Played By PBMs And Drug Makers Limits Biosimilar Competition

Forbes Healthcare

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S. patient out-of-pocket costs are too high.

112
112